V
Virax Biolabs Group Ltd
NASDAQ:VRAX
Virax Biolabs Group Ltd
NASDAQ:VRAX
Price:
0.225
USD
3.21%
Market Closed
Market Cap:
$1.7m
Cash Flow Statement
Cash Flow Statement
Virax Biolabs Group Ltd
Virax Biolabs Group Ltd
Currency: USD
| Mar-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Net Income |
(2)
|
(5)
|
(8)
|
(7)
|
(7)
|
(6)
|
(6)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
2
|
2
|
1
|
1
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
1
|
1
|
2
|
2
|
1
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
(0)
|
(1)
|
(1)
|
0
|
1
|
(0)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(4)
-416%
|
(8)
-86%
|
(6)
+20%
|
(5)
+27%
|
(5)
+0%
|
(5)
-18%
|
|
| Investing Cash Flow | ||||||||
| Capital Expenditures |
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Cash from Investing Activities |
0
N/A
|
(0)
N/A
|
(1)
-397%
|
(1)
-31%
|
(1)
+40%
|
(1)
+14%
|
(0)
+18%
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
1
|
14
|
14
|
2
|
8
|
6
|
2
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Financing Activities |
1
N/A
|
14
+1 590%
|
14
+0%
|
2
-88%
|
7
+352%
|
6
-22%
|
2
-66%
|
|
| Change in Cash | ||||||||
| Net Change in Cash |
0
N/A
|
9
N/A
|
5
-45%
|
(6)
N/A
|
2
N/A
|
1
-71%
|
(4)
N/A
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(1)
N/A
|
(4)
-438%
|
(9)
-99%
|
(7)
+14%
|
(5)
+29%
|
(5)
+2%
|
(6)
-14%
|
|
Switch to:
Switch to:
See Also
Discover More
